DVT Prevention in Joint Arthroplasties: Continuous Enhanced Circulation Therapy vs. Low Molecular Weight Heparin
Y. Gelfer, H. Tavor, A. Or on, A. Peer, N. Halperin, D. Robinson.
The Journal of Arthroplasty, February 2006; 21(2): 206-214
Efficacy: The C.E.C.T protocol was significantly more effective than enoxaparin in reducing DVT
Safety: Safety profiles were similar in both groups
Learn more about the study
What did the study compare?
The study compared the effectiveness of theActiveCare® Therapy with or without Aspirin versus Lovenox® in DVT prevention in patients undergoing total knee or total hip replacement surgeries.
How was the study designed?
121 patients participated in this study. 61 randomly chosen patients received ActiveCare® Therapy and other 60 patients received Lovenox® .
How were the results tested?
5-8 days after the surgery patients had bilateral venography to detect DVT. Any symptomatic DVT events were collected for up to 90 days postoperatively.
The patients in ActiveCare® therapy had significantly less DVT than those on Lovenox®.